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Abstract
Background: LEA (late embryogenesis abundant) proteins encode conserved N-terminal mitochondrial signal domains and
C-terminal (A/TAEKAK) motif repeats, long-presumed to confer cell resistance to stress and death cues. This prompted the
hypothesis that LEA proteins are central to mitochondria mechanisms that connect bioenergetics with cell responses to
stress and death signaling. In support of this hypothesis, recent studies have demonstrated that mammalian LEA protein
PRELI can act as a biochemical hub, which upholds mitochondria energy metabolism, while concomitantly promoting B cell
resistance to stress and induced death. Hence, it is important to define in vivo the physiological relevance of PRELI
expression.
Methods and Findings: Given the ubiquitous PRELI expression during mouse development, embryo lethality could be
anticipated. Thus, conditional gene targeting was engineered by insertion of flanking loxP (flox)/Cre recognition sites on
PRELI chromosome 13 (Chr 13) locus to abort its expression in a tissue-specific manner. After obtaining mouse lines with
homozygous PRELI floxed alleles (PRELI
f/f), the animals were crossed with CD19-driven Cre-recombinase transgenic mice to
investigate whether PRELI inactivation could affect B-lymphocyte physiology and survival. Mice with homozygous B cell-
specific PRELI deletion (CD19-Cre/Chr13 PRELI
2/2) bred normally and did not show any signs of morbidity. Histopathology
and flow cytometry analyses revealed that cell lineage identity, morphology, and viability were indistinguishable between
wild type CD19-Cre/Chr13 PRELI
+/+ and CD19-Cre/Chr13 PRELI
2/2 deficient mice. Furthermore, B cell PRELI gene expression
seemed unaffected by Chr13 PRELI gene targeting. However, identification of additional PRELI loci in mouse Chr1 and Chr5
provided an explanation for the paradox between LEA-dependent cytoprotection and the seemingly futile consequences of
Chr 13 PRELI gene inactivation. Importantly, PRELI expression from spare gene loci appeared ample to surmount Chr 13
PRELI gene deficiency.
Conclusions: These findings suggest that PRELI is a vital LEA B cell protein with failsafe genetics.
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Introduction
In attempting to understand how mitochondria bioenergetics is
biochemically connected with stress and death signaling, recent
studies found that PRELI (protein of relevant evolutionary and
lymphoid interest) [1,2] is a key mammalian LEA ortholog
inherently involved in mechanisms that regulate mitochondria
biogenesis, energy metabolism, and cell survival [3,4,5]. Impor-
tantly, PRELI was shown to interact with dynamin-like GTPase
OPA1 [6] to keep cristae junctions intact, control molecular
current [5,7], and support critical biochemical mitochondria
functions. For instance, mitochondria convert organic compounds
into CO2 and H2O to produce energy in the form of ATP, via
respiratory chain (RC) oxidative phosphorylation reactions
[5,7,8,9]. These reactions were found to be enhanced by PRELI
expression, thus enabling RC progression from complex I to V
and ensuring the maintenance of the mitochondrial membrane
potential (Dym) [5,10,11]. Notably, the mitochondrial Dym
supports energy metabolism, regulates reactive oxygen species
(ROS) production and controls the traffic of pro- and anti-
apoptotic molecules [5,12,13]. As such, the mitochondrial Dym
becomes a conductance core, where crosstalk between bioener-
getics and apoptosis signaling directs cell responses and fate [14].
In keeping with this notion, LEA protein-dependent mainte-
nance of the mitochondrial Dym is essential to prevent ROS
surges, promote the assembly of survival protein networks and
restrain the release of hallmark contributors of programmed and
induced cell death [5,12,14,15,16]. Remarkably, the intrinsic
mitochondria-dependent cytoprotection functions that are rele-
vant to LEA-containing proteins like PRELI, have been docu-
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animals, in which evolutionary parallels of cell responses to stress
and death-inducing stimuli are well established
[3,5,17,18,19,20,21]. Furthermore, yeast (Ups1p) and mammalian
PRELI locate within mitochondria inter-membrane space (IMS),
interact with respective yeast Mgm1p or mammalian OPA1 at
cristae junctions, and play analogous roles in mitochondria
biogenesis and cell survival [5,17,22]. Moreover, human and
mouse PRELI proteins are 96.3% identical and exhibit robust and
ubiquitous expression during embryo development [1,2], which
supports the notion of evolutionarily conserved mechanisms for
eukaryote cell development and survival [3,4,5,17,23].
Therefore, to directly assess the physiological significance of
mammalian LEA-containing proteins in vivo, we sought to
conditionally target the mouse Chr13 PRELI gene, the only
known locus at the time these studies were undertaken. The
findings reported herein and the recent disclosure of additional
PRELI gene copies in Chr1 and Chr5 provide evidence that
failsafe mechanisms are genetically imprinted to ensure the
expression of genes that are necessary for cell survival.
Results
Protein structure features defining PRELI physiology
As mammalian LEA proteins, human and mouse PRELI display
conserved MSF1-like domains and C-terminal coiled-coil (CC)
LEA motif (A/TAEKAK) repeats [2,3,5,23]. The hypothetical
MSF1-like domain (Fig. 1a) spans a 170 amino acid module,
which is known to assume globular a/b conformations and harbor
pleckstrin homology (PH) regions, phosphothyrosine binding
(PTB) sites, epsin N-terminal homology (ENTH) motifs and 4.1
Ezrin-Radixin-Moesin (FERM) domains [24,25]. These structures
are characteristic of signal transduction proteins involved in the
regulation of mitochondrial molecular traffic [24,25]. Relevant to
PRELI mechanisms of action, the MSF1-like sequence comprises
N-terminal mitochondria localization signals [26]. Thus, to further
attest the relevance of the MSF1-like structure in defining PRELI
expression in the mitochondria, control (Vector) and PRELI Blin-1
transfectants were comparatively analyzed by immunofluores-
cence staining and confocal microscopy. Consistent with PRELI N-
terminal structure, Figure 1b reveals a selective expression of the
mammalian LEA protein, in the mitochondria by PRELI Blin-1
transfectants. Markedly, the parental Pre-B acute lymphocytic
leukemia (PreB ALL) Blin-1 cell line [27] did not express
detectable PRELI levels, which underscored its sensitivity to
caspase-dependent and independent apoptosis [5].
Equally important to PRELI structure-dependent features, the
tandem LEA (A/TAEKAK) repeats are configured as two a helices
in opposite orientation, which are flanked by low complexity (LC)
regions (Fig. 1a) and characterize proteins that confer stress
tolerance and resistance to death [3,5,18,21,28]. In agreement
with this notion and in further support of earlier findings [5],
figure 1c shows that PRELI expression is essential to confine
apoptosis inducing factor (AIF) [29] in the mitochondria and thus
prevent caspase-independent death. Notably, AIF release from the
mitochondria results in direct DNA fragmentation and virtually
immediate cell destruction [5]. Thus, the potent LEA protein-
dependent cytoprotection was emphasized by the evidence that in
contrast to control Blin-1 transfectants (Fig. 1c top), the imminent
and devastating death resulting from AIF redistribution was largely
preventable in PRELI expressing cells (Fig. 1c, bottom).
PRELI expression during mouse embryo development
LEA gene expression in all eukaryote studied is selectively
prominent during embryo development and when organisms are
exposed to stress and/or life-threatening conditions
[3,5,18,20,21,23,30]. This suggested that in vivo, PRELI expression
could be crucial for mammalian embryo development and when
cell survival is intrinsically connected with mitochondria mecha-
nisms that control stress tolerance and resistance to death [5]. In
support of this hypothesis, northern blot and fluorescent in situ
hybridization (FISH) analyses showed that PRELI mRNA
expression was robust and ubiquitous throughout all mouse
embryo stages (Fig. 2a and b). Although northern blot results
depicted strong mRNA levels at 7, 11, 15, and 17 days post coitum
(dpc), which vitually overlapped with the FISH data, the former
aimed to verify PRELI mRNA molecular size while the latter
intended to mainly illustrate the overall tissue distribution of the
transcript. Moreover, the 13-dpc FISH image revealed a
developmental stage not represented in the northern blot results
and thus complemented PRELI expression analyses. Of note, the
prominent 1.1 kb mRNA size detected by northern blotting, is the
only mouse transcript that has been routinely confirmed by
Figure 1. PRELI motifs and their relevance in subcellular
location and function. (a) Hypothetical PRELI structure based on
queries of deduced amino acid sequence against protein databases
(http://wwwuniprot.org/uniprot/Q8R107; http://pfam.sanger.ac.uk/
family/PF04707). PRELI MSF1-like region is depicted as a dark grey
octagonal form, while its LEA motif is shown as theoretical a helices,
flanked by low complexity (LC) domains (lighter grey rectangles). (b)
Confocal microscopy results on control (Vector) and PRELI PBlin-1
transfectants [5] confirm MSF1-like deduced prediction that N-terminal
signal peptide mvkyflgqsvlrsswdqvfaafwqrypnpyskhvl can direct
PRELI expression (red fluorescence) into the mitochondria, as shown by
its co-localization (merge) with mitochondrial HSP60 (green fluores-
cence) [5]. (c) Confocal microscopy results show that in contrast to
control cells (Control), PRELI Blin-1 transfectants (PRELI) [5] prevent STS-
induced (+STS) release of AIF from the mitochondria and uphold cell
morphology and survival. These results are consistent with the
conserved cytoprotection function of LEA-containing proteins. AIF is
shown in red fluorescence within greyscale cell background.
doi:10.1371/journal.pone.0037949.g001
Vital Physiology with Backup Genetics
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37949annotated sequencing data (National Center for Biotechnology
Information and The European Molecular Biology Organization
databases). Therefore, the weak but noticeable 7.5 kb mRNA
bands detected at 11 and 15 dpc are likely the result of
unprocessed transcripts. These collective results parallel LEA gene
expression traits found in most eukaryotes.
PRELI mRNA tissue distribution in adult mice
Earlier studies have shown that LEA proteins in general and
PRELI in particular connect mitochondria bioenergetics with
mechanisms that are essential for cell survival [3,5,31]. In keeping
with this notion, PRELI mRNA tissue distribution in adult mice
was found to be predominant in the thymus, spleen, lymph nodes,
brain, lungs, and kidneys (Fig. 2c). These are tissues in which cells
are under rigorous selection pressure [32,33,34] and mitochon-
dria-dependent functions drive cell responses to stress and death
stimuli [35,36]. For instance: (a) Lymphocyte maturation
programs in the thymus, spleen and lymph nodes entail stringent
selection mechanisms that ensure the survival of immunocompe-
tent cells and elimination of aberranly developed cells [32,33]; (b)
Similarly, high energy-driven mechanisms are central for brain cell
survival [35]; (c) Lung cell survival is constantly challenged by
oxidative toxicity and pathogen-driven inflammatory strain [34];
(d) In kidney cells, strenuous Na
H+/Cl
e2 exchanges are charac-
teristic functions that sustain tissue hydration, osmolarity and
survival, which parallel bioenergetic H
+/e
2 gradients that protect
plant cells from pH collapse, desiccation, and death [19,28,30]; (e)
Lastly, like immune cells, germ cells in the ovary undergo
maturation selection cycles, which result in the ovulation of the fit
and the demise of cells failing maturation demands [36].
It is noteworthy that while mitochondria bioenergetics is
inherently associated to cellular activity in the testis, heart, skeletal
muscle and liver, PRELI mRNA levels were virtually undetectable
in these organs under homeostatic contitions (Fig. 2c). However, it
is conceivable that PRELI expression is most prominently required
when energy demands are intrinsically linked to cell responses to
stress death signaling [5]. This suggests that PRELI expression
could be under strict genetic and/or epigenetic regulatory
constraints and hence, transcriptional activation could also depend
on stress-mediated stimulation, including hypoxia, hypertension or
inflammatory reactions.
In added support of the physiological connection of stress and
death signaling with PRELI expression and mechanisms of cell
survival, spleen and lymph node germinal center (GC) B cells are
programmed to die unless they can recognize pathogen determi-
nants (also known as antigens) with high affinity [32]. Thus, GC B
cell affinty maturation is a stringent selection process and timely
PRELI expression could be required to ensure the survival of high-
affinty/antigen-binding GC B cells. Consistent with this hypoth-
esis, figure 2d shows that PRELI expression is selectively expressed
by GC precursors and GC B cells.
Together, these data suggest that similar to most LEA genes,
PRELI expression is necessary for embryo development and
important for stress tolerance and resistance to programmed and
induced death in adult mice. Therefore, gene inactivation
experiments were sought to appraise in vivo PRELI physiology.
Conditional PRELI gene targeting in mice
Gene targeting experiments were undertaken with the aim to
inactivate mouse PRELI gene expression in vivo and define its
biological significance. As a means to circumvent potential embryo
lethality, a conditional gene-targeting strategy was devised to
achieve PRELI gene inactivation in a cell lineage-restricted
manner. As shown in Figure 3a, flanking loxP (flox)/Cre
recognition sites were engineered in the targeting construct in a
manner so that sites could be inserted adjacent to exon II of
homologous chromosome 13 (Chr 13) PRELI gene. In this context,
the transfer of exon II with flanking loxP sites (floxed target) into
the Chr 13 PRELI locus of embryonic stem cells (ESC) could be
achieved by homologous recombination. The rationale for loxP
sites adjacent to exon II was based on sequence database analyses,
which showed that only introns I and II sequences were exempt
from regulatory sequences that are transcriptionally relevant to
adjacent genes (Fig. 3a). Thus, in agreement with this reasoning,
deletion of exon II was designed to interrupt PRELI expression
without affecting neighboring Rab24 or Mad3 (Fig. 3a) gene
transcription.
After obtaining mouse lines with homozygous Chr 13 PRELI
floxed alleles (Chr 13 PRELI
f/f mice), as confirmed by polymerase
chain reaction (PCR) analyses (Fig. 3b), the animals were bred into
the C57BL/6 background to generate and study genetically equal
PRELI
f/f mouse strains. Although the overall aim in the design and
generation of PRELI
f/f mice was to provide flexible means to assess
the requirement of PRELI expression in a broad range of cell
lineages, primary breeding with the CD19-Cre transgenic (Tg)
mice was chosen for several reasons: (i) PRELI was discovered for
its prominent expression in GC B cells [1], which are known for
Figure 2. PRELI mRNA expression during mouse embryo
development and in adult life. (a) Northern blot results show the
prominent PRELI mRNA expression at 7–17 days post coitum (dpc)
stages of mouse embryo development. (b) In situ hybridization results
of whole-mount embryo sections show robust and ubiquitous PRELI
mRNA expression at 13-dpc developmental stage. Left: hybridization
with digoxigenin-labeled anti-sense PRELI complementary RNA (cRNA)
probe shows prominent red fluorescence overlapping with Hoechst
blue fluorescence counterstain. Right: hybridization with sense cRNA
probe, which largely exhibits the blue fluorescence of the counterstain,
serves as control for PRELI mRNA detection specificity. (c) Northern blot
results show PRELI expression by distinct adult mouse tissues: bone
marrow (1), thymus (2), spleen (3), lymph node (4), testis (5), ovary (6),
brain (7), skeletal muscle (8), heart (9), stomach (10), liver (11), lung (12)
and kidney (13). Ethidium bromide-stained images of 28S and 18S
ribosomal RNA bands, retained on nitrocellulose blots after capillary
transfer, are shown as control for RNA sample loading (d) Left: Cell
sorting scheme used for RNA isolation from naı ¨ve IgD
+GL-7
2 (1),
germinal center (GC) precursors IgD
+GL7





2 (4) B cell subsets. Right: RT-PCR results reveal PRELI
mRNA expression by the distinct B cell subsets. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) mRNA amplification is presented as
control of B cell subset RNA content.
doi:10.1371/journal.pone.0037949.g002
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important to define the impact of its inactivation in these cells; (ii)
the successful breeding with CD19-Cre mice is well documented
[37,38]; and (iii) the CD19-Cre mice are readily available from
approved animal repositories.
PRELI gene deletion without expression loss
After breeding the Chr 13 PRELI
f/f mouse strain with CD19-
Cre Tg animals, litters of wild type (WT) CD19-Cre/Chr13
PRELI
+/+, heterozygous CD19-Cre/Chr13 PRELI
+/2, and ho-
mozygous CD19-Cre/Chr13 PRELI
2/2 mice were obtained and
their genotype routinely verified by Southern blotting (Figure 3c).
As a rigorous measure, blots were independently confirmed with
external 59 and 39 probes, whose respective sequences are located
outside the regions of homology with the targeting vector (Fig. 3a).
Homozygous CD19-Cre/Chr13 PRELI
2/2 mice bred normally
and did not have any detectable signs of morbidity. Post mortem
examination of lymphoid organs, from cohorts of euthanized mice,
showed no discernible differences in B cell lineage phenotype,
homing, or viability between WT CD19-Cre/Chr13 PRELI
+/+
and homozygous CD19-Cre/Chr13 PRELI
2/2 littermates. For
instance, flow cytometry analyses of CD45/B220
+ and CD19
+
cells [34] in peripheral blood leukocytes (PBL) showed that overall
leukocyte cellularity (B220) and B lineage-specific (CD19) cell
numbers were virtually identical in WT CD19-Cre/Chr13
PRELI
+/+, heterozygous CD19-Cre/Chr13 PRELI
+/2, and ho-
mozygous CD19-Cre/Chr13 PRELI
2/2 mice (Fig. 4). Further-
more, analyses of offspring resulting from the breeding of PRELI
f/f
mouse lines with ubiquitous CMV-driven Cre expressing mice
gave similar results as those obtained with CD19-Cre (not shown).
Although no other LEA genes with similar PRELI structure and
mechanisms of action have been identified in mammals, functional
redundancy with other gene families was plausible. Therefore,
defining mRNA and protein expression status in CD19-Cre/
Figure 3. Conditional Chr 13 PRELI gene Targeting. (a) Overall Schema I: WT allele depicts PRELI gene flanked by Rab 24 (left) and Mad3 (right)
genes; II: Targeting vector construct displays relevant restrictions sites (Asc1 [A], BamH1 [B], Cla1 [C], EcoR1 [R1], Not1 [N], Pme1 [P], Sal1 [S], and Xba1
[X]). Also indicated are 59 and 39 arms of homology, LoxP sites, Flip recombination (Frt) sequences, and PGK-Neo and HSV-Tk selection cassettes; III:
Floxed PRELI allele, after Frt-mediated removal of selection cassettes; IV: PRELI deficient allele after CD19-driven Cre recombinase (Cre) cleavage of
PRELI exon II. Location of 59 and 39 external probes used in Southern Blot hybridization experiments is indicated. (b) PCR genotyping results of mouse
litters after Chr13 PRELI gene targeting (Flox insertion) and Frt-mediated removal of PKG-Neo cassette but before breeding with CD19-Cre mice.
Several PCR reaction products from Chr13 PRELI
f/f mice are compared to those of Chr13 PRELI
+/f and Chr13 PRELI
+/+ littermates. A PRELI gene PCR
reaction from CD19Cre mouse DNA is included as an additional Chr13 PRELI
+/+ control. Predicted sizes of amplified DNA from PRELI
+/+ and PRELI
f/f
alleles are indicated. (c) Southern blot genotype results of the conditionally targeted mouse strain after breeding with CD19-Cre mice. (Left) Southern
blot analysis of BamH1 digested genomic DNA from WT CD19-Cre/Chr13 PRELI
+/+, heterozygous CD19-Cre/Chr13 PRELI
+/2 and homozygous CD19-
Cre/Chr13 PRELI
2/2 mice hybridized to the 59 external probe (illustrated above). Because all mouse lines tested here are in the C57BL/6 genetic
background, a WT control from C57BL/6 (BL6) genomic DNA (first lane on the blot) is also included. (Right) Southern blot analysis of EcoR1 and Sal1
digested DNA from heterozygous CD19-Cre/Chr13 PRELI
+/2, WT CD19/Cre/Chr13 PRELI
+/+ and homozygous CD19-Cre/Chr13 PRELI
2/2 mice
hybridized to the 39 external probe (illustrated above). Expected molecular sizes are also indicated.
doi:10.1371/journal.pone.0037949.g003
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could be concluded. Strikingly, northern blot and quantitative
reverse transcription-mediated PCR (qRT-PCR) [39,40,41] re-
vealed that PRELI mRNA expression in bone marrow and spleen
B cells was virtually unaffected in homozygous CD19-Cre/Chr13
PRELI
2/2 mice (Fig. 5a and b), despite proven Chr13 PRELI gene
deletion (Fig. 3b and c). Moreover, northern blot results showed no
discernible differences in PRELI mRNA molecular sizes between
WT CD19-Cre/Chr13 PRELI
+/+ and homozygous CD19-Cre/
Chr13 PRELI
2/2 littermates, even though exon II spans nearly
one fourth (226 bp) of the entire 1.1 kb transcript sequence.
Nevertheless and although Chr13 PRELI gene targeting was
engineered to completely prevent transcription, exon II-skipping,
which could generate truncated PRELI transcripts and proteins
required to be ruled out. To that end, amplification of full-length
PRELI open reading frame (ORF), directional cDNA cloning, and
immunoblotting experiments were performed using RNA and
protein extracts from CD19-Cre/Chr13 PRELI KO peripheral
blood leukocytes (PBL), to verify PRELI mRNA and protein
molecular sizes and examine the nucleotide sequence of the
amplified ORF. Figure 6 demonstrates that the amplified 672
ORF (Fig. 6a), the 25-kDa polypeptide (Fig. 6b), and the exon II-
retaining full-length cDNA sequence (Fig. 6c) derived from RNA
and protein extracts of CD19-Cre/Chr13 PRELI KO PBL,
encode intact PRELI gene products.
These results, together with the evidence of conditional Cre-
mediated Chr13 PRELI gene deletion (Fig. 3b and c) suggested
that the PRELI mRNA and protein expression observed in
homozygous CD19-Cre/Chr13 PRELI
2/2 mice could not have
originated from the Chr 13 locus. It is therefore conceivable that
complementary loci, encoding LEA proteins of related or identical
gene pool, could operate in concert to overcome Chr13 PRELI
deficiency.
Spare PRELI loci compensate the Chr 13 PRELI gene
deficiency
In support of this hypothesis, updates of mouse databases
revealed the presence of additional PRELI gene copies in mouse
chromosome 5 and 1. Strikingly, PRELI copy in Chr5 is an
intronless gene (Fig. 7a) and transcribes mRNAs, whose deduced
amino acid sequence is 100% identical to that encoded by the
Chr13 PRELI gene (Fig. 7b). Similarly, Chr1 PRELI gene is also
intronless (Fig. 7a) but its nucleotide sequence is only 98%
identical to Chr5 and 13 genes (not shown). The distinctive
nucleotide divergence of the Chr1 PRELI gene from those of Chr5
and 13 loci appears to give rise to premature stop codons, which
would preclude PRELI-like translation. However, the annotated
nucleotide sequence data was generated from pooled DNA of
diverse mouse strains and hence, the likelihood of strain-related
polymorphisms and/or nucleotide mismatches cannot be com-
pletely excluded. Nevertheless, the prominent PRELI mRNA and
protein levels found in all homozygous CD19-Cre/Chr13
PRELI
2/2 mouse lines examined indicate that overall expression
is amply sufficient to surmount Chr13 PRELI gene deficiency,
irrespective of whether it originated from Chr5 PRELI alone or
from combined Chr5 and Chr1 PRELI gene transcription.
Moreover, the compensatory PRELI mRNA and protein expres-
Figure 4. Cell lineage phenotype analyses of CD19Cre/Chr13
PRELI mice. Flow cytometry results compare the presence of B220
+
(left histograms) and CD19
+ (right histograms) lymphocytes in
peripheral blood leukocytes of WT CD19/Cre/Chr13 PRELI
+/+ (top),
heterozygous CD19-Cre/Chr13 PRELI
+/2 (middle), and homozygous
CD19-Cre/Chr13 PRELI
2/2 mice (bottom). Results are presented as
number of cells (%) with relevant fluorescence (Log) staining. The figure
is a representative result of at least three independent analyses
performed with age-matched littermates (n = 3). Standard error mean
(6 SEM) bars are indicated and high statistical significance values
scored p#0.001.
doi:10.1371/journal.pone.0037949.g004
Figure 5. PRELI transcription by CD19Cre/Ch13 PRELI mice. (a)
Northern blots compare PRELI mRNA levels between WT CD19/Cre/
Chr13 PRELI
+/+ and heterozygous CD19-Cre/Chr13 PRELI
+/2 or homozy-
gous CD19-Cre/Chr13 PRELI
2/2 mouse spleen B cells. (b) qRT-PCR
assessment of PRELI transcription between WT CD19/Cre/Chr13 PRELI
+/+
and homozygousCD19-Cre/Chr13 PRELI
2/2 mice. qRT-PCR comparisons
include results obtained with RNA from bone marrow and spleen B
cells. Data are presented in relative Ct and are the result of at least three
WT CD19/Cre/Chr13 PRELI
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2/2 mice was vastly kept at
physiological levels. Therefore, retention of B cell responses to
stress and death signaling is anticipated. These findings addition-
ally suggest that inter-chromosomal PRELI gene duplication
represent evolutionarily conserved LEA-dependent mechanisms
to preserve vital physiology.
In further support of the relevance of in vivo PRELI functions,
recent studies have demonstrated that transgenic (Tg) mice
ubiquitously expressing high levels of mutant PRELI proteins that
lacked the functional LEA motif (PRELI/LEA
2) succumbed at
early embryo stages [5]. PRELI/LEA
2 Tg embryos died of
massive apoptosis, caused by a dominant-negative molecular
hindrance, which prevented endogenous LEA-dependent cytopro-
tection and severely compromised mouse development [5].
Moreover, Tg mice in which mutant PRELI/LEA
2 expression
was driven by the endothelial and hematopoietic cell lineage-
specific vav promoter [42,43], died of systemic haemorrhages
within five weeks of postnatal life and showed poor lymphoid
organ development [5]. Remarkably, no other proteins with
similar tissue distribution, mitochondria localization and pro-
survival functions could circumvent PRELI/LEA
2 Tg lethality,
thus emphasizing the unique LEA-dependent mechanisms that are
essential for plant and animal embryo development and cell
survival [3,4,5,18,20,21,23,30,31].
Thus, the present work emphasises the conserved cytoprotection
activity of LEA-containing proteins in general
[1,3,4,5,18,20,21,28] and supports the vital PRELI physiology,
which could be upheld by spare chromosome imprints that confer
failsafe genetic means to ensure the survival of cells undergoing
Figure 6. CD19-Cre/Ch13 PRELI
2/2 transcripts have exon II sequences. (a) RT-PCR results of peripheral blood leukocyte (PBL) PRELI transcript
amplification from WT CD19/Cre/Chr13 PRELI
+/+, heterozygous CD19-Cre/Chr13 PRELI
+/2, and homozygous CD19-Cre/Chr13 PRELI
2/2 mouse
littermates. A 2.5–0.3 kb molecular weight marker range is shown on the left of the ethidium bromide-stained gel image to verify the length of PRELI
open reading frame (ORF). The predicted 670 bp molecular size of PRELI ORF PCR fragments includes forward and reverse amplifying primers with
respective restriction endonuclease EcoR1 and Sal1 sequences (depicted in section c). (b) Immunoblot results reveal PBL PRELI protein levels in WT
CD19/Cre/Chr13 PRELI
+/+, heterozygous CD19-Cre/Chr13 PRELI
+/2, and homozygous CD19-Cre/Chr13 PRELI
2/2 mice. Of note, the same blot was
divided into high and low molecular mass (kDa) sections, indicated by the intersect mark (?) at proportional kDa boundaries. This strategy enables
the assessment of PRELI expression (24.9 kDa) and at the same time, permits to independently monitor protein loading (MSF1-like) on identical
sample lanes. (c) cDNA sequencing results obtained from a representative homozygous CD19-Cre/Chr13 PRELI
2/2 clone obtained after RT-PCR
amplification (section a). Amplifying forward and reverse primers are shown in bold font and respective EcoR1 and Sal1 restriction endonuclease
target sequences are indicated in grey font. Canonical translation initiation and stop codon sequences are circled, while exon II is framed. This
sequence is identical to NCBI database annotation XM_001476721.
doi:10.1371/journal.pone.0037949.g006
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[5,32,44].
Discussion
Eukaryote cells react to stress and death-inducing stimuli by a
coordinated transduction of signals that trigger the expression of
genes that are relevant for cell homeostasis and survival
[20,21,30,45]. In keeping with this notion, LEA motif-containing
genes encode an evolutionarily conserved family of proteins, which
have emerged as archetypal protectors of eukaryote cells against
stress and death cues [3,4,18,20,21,23,28,30,31]. Although LEA
proteins were first identified and studied in plants
[19,28,30,45,46], a decade of broad prokaryote and eukaryote
research emphasizes their evolutionary conservation and biolog-
ical impact in stress tolerance [1,5,20,21,31,47]. For instance, the
Drosophila proteins prel (PRELI-like), slmo (slowmo) and retm (real-time)
proteins constitute a family of mitochondrial LEA-containing
orthologs, which also possess conserved MSF1-like domains and
are activated during embryo development [3,23]. Analogous to
plants, nematodes use LEA-dependent anhydrobiosis functions as
protective means against dehydration [20,48]. Moreover, Ups1p is
a yeast LEA protein that is localized within mitochondrial
intermembrane space (IMS), whose known interactions with
Mgm1p keep mitochondria cristae junctions tight and prevent the
exit of apoptogenic molecules [4,17].
As the first example of LEA-containing proteins in vertebrates,
the PX19 gene is an avian ortholog, whose expression is induced in
response to stress-inducing bromodeoxyuridine and appears to be
critical for haematopoietic cell development [18]. Among verte-
brates, PRELI is a mammalian LEA-containing protein with N-
terminal mitochondrial localization MSF1-like signals and tandem
C-terminal repeats of the LEA domain [1,2]. Identical to yeast
Ups1p, PRELI locates within the IMS and interacts with OPA1, the
mammalian homolog of yeast Mgm1p [6,22], to uphold mitochon-
dria membrane potential Dym, support oxidative phosphorylation
Figure 7. Additional PRELI gene copies in Chr 5 and 1 loci. (a) Top: Relative PRELI gene location in Chr 5 is shown with distance/direction
coordinates (black triangles) and accession number; transcript database annotation at (http://www. ncbi.nlm.nih.gov/sites/entrez?db=gene&cm-
d=retrieve&log%20$=%20seqviewge ne&list_uids=100046650) is provided; 59-39 transcript orientation with respect to the gene locus is indicated
by a thick black arrow; and protein annotation, which also originated from the same uniform resource locator (URL) link shown above, depicts
deduced 59 and 39 untranslated regions (in grey) and coding open reading frame (in black). Bottom: Designated PRELI gene location in Chr 1, which
includes distance/direction coordinates (black triangles) and database accession number. It also displays database annotation of respective transcript
at (http://www.ncbi.nlm.nih.gov/entrez?db=gene&cmd=retrieve&log%20$=%20seq view_gene&list_uids=675389) and its relative 59-39 direction
with respect to the gene locus is shown by a thick black arrow. A region spanning the predicted mRNA is shown as a grey rectangle. (b) Amino acid
sequence alignment between proteins respectively encoded by Chr 13 and Chr 5 PRELI gene loci is shown in color-coded format: A numbered
consensus generated by the Clustal alignment software (see methods) is shown in black font, while Chr 13 PRELI and Chr 5 PRELI amino acid
sequences are respectively aligned in dark and grey font.
doi:10.1371/journal.pone.0037949.g007
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human PRELI can biochemically and functionally substitute yeast
Ups1p in the mitochondria [17], further emphasizes their
biological resemblance.
In view of the widespread support of LEA protein physiology in
eukaryote cell protection against death-inducing stimuli
[1,3,4,18,20,21,28,30,31] and given the robust PRELI transcript
levels during embryo development [5], the rational inference was
that LEA gene expression could be vital in mammals. Consistent
with this hypothesis, Tg mice with dominant-negative PRELI/
LEA
2 expression died at early embryo stages or soon after birth, as
a result of molecular hindrance preventing endogenous PRELI
functions [5]. Furthermore, additional PRELI gene copies in
mouse Chr 5 and 1 have been identified (Fig. 7), whose expression
seems sufficient to keep mRNA and protein expression at
physiological levels and thus overcome Chr13 PRELI gene loss.
Relevant to the safeguard of essential biology, LEA proteins in
plants and animals are recognized for their multiple gene copy
distribution within the same organism [31]. In plants, fourteen of
the 51 LEA genes, grouped into nine classified families, are
duplicated [49,50]. The imprinted LEA genetics for physiological
safety can therefore be interpreted as evolutionarily conserved
means to keep organelle structures intact and thus ensure cell
functions and survival. These include, maintenance of mitochon-
dria cristae junctions to support RC oxidative phosphorylation
reactions, uphold osmolarity, regulate ROS levels, prevent
dehydration, and protect cells against thermodynamic shock-
induced stress [5].
Remarkably, LEA gene duplication is not restricted to plants
[31] and thus, the relatively homogenous distribution of spare
copies either within the same or distinct chromosomes [50] likely
reflects conserved measures to bank essential genetics, via inter
and intra-chromosome gene repeats. In nematodes, homologous
avLEA and ceLEA proteins regulate tolerance to desiccation-
induced stress and overall protein stabilization functions [20,21].
Although identical LEA gene duplicates are yet to be identified in
Drosophila, this species counts on the PRELI-like proteins Slmo, Prel
and Retm to home in the mitochondria and sustain RC-dependent
ATP synthesis [3,23]. In the same context, yeast Ups1p and Ups2p
share remarkable resemblance with PRELI in supporting mito-
chondria structure integrity and physiology [4,17].
The present study speculates that LEA proteins in mammals
possess gene duplication traits equivalent to those observed in
plants [31,49,50]. Consistent with this theory, gene and protein
databases have revealed that the mouse carries at least two spare
PRELI gene copies in Chr 5 and Chr 1 (Fig. 7). Importantly, the
probability of persistent PRELI expression, originating from
duplicate gene loci is high for Chr 5 PRELI and conceivable for
Chr 1 PRELI genes. It is therefore plausible that gene expression
from Chr 5 PRELI or in conjunction with Chr 1 PRELI locus
occurs as a means to preserve functions that are essential for
mouse embryo development and cell survival. However, it must be
noted that although the presence of spare PRELI genes represent
backup means to circumvent the loss of the Ch 13 locus,
expression in CD19-Cre/Ch 13 PRELI
2/2 mouse B cells remains
under the same genetic and epigenetic regulatory mechanisms as
those of WT B cells. In this context B cell PRELI expression is also
under physiologic control of cell development and maturation
signals.
In conclusion, the data presented and discussed in this study
highlight the biological significance of LEA proteins in general and
PRELI in particular, whose physiology links mitochondria
biogenesis, energy metabolism, and cell responses to stress and
death signaling [5]. The impact of these functions, which involve
hallmark mechanisms relevant to embryo organogenesis, devel-
opment and survival in plants and animals
[3,4,5,17,18,20,21,28,30], stems from the remarkable array of
LEA proteins across evolution and the inherent capacity to
undergo gene locus duplication [31,49,50]. In keeping with this
concept, LEA genes epitomize conserved molecular models that
have been long presumed to portray backup genetics applied to
mechanisms of cell preservation [49,50]. The fact that mouse
PRELI gene undergoes inter-chromosomal gene duplication
provides experimental support to such prediction and suggests
that spare Chr 5 and potentially Chr 1 PRELI loci (Fig. 7) play
genetically meaningful roles to uphold cytoprotection functions
after Chr 13 PRELI gene loss. Lastly and to underscore the
relevance of the evolutionary conservation of LEA duplication
traits, figure 8 summarizes gene database annotations, as evidence
that human PRELI gene also undergoes inter-chromosomal
duplication at Chr 5q35.3 and Chr 6q22.32. Notably, human
Chr 5 and 6 PRELI loci are confirmed spare gene copies, which
encode amino acid sequence that are 100% identical to the
Q9Y225 protein annotation (Fig. 8).
Although future research will provide full appraisal of PRELI
biological significance, the present study aims to share information
deemed relevant to the broad Biology field.
Materials and Methods
Cloning and Sequencing
A mouse spleen cDNA library (Clontech Laboratories, Inc.,
Palo Alto, CA) was screened by hybridization to a human PRELI
cDNA probe. A selected clone was purified, sequenced (DNA
Sequencing Core Facility, UT-MDACC) and found to be identical
to an annotated sequence in the National Center for Biotechnol-
ogy Information (NCBI) database: Accession # XM_001476721.
The sequence information served to retrieve a Chr 13 bacterial
artificial chromosome (BAC) clone (Accession # NT_039589),
which was used as the base to design the strategy for conditional
PRELI gene targeting in mice.
Figure 8. Spare PRELI gene copies in humans. This figure provides
mRNA and protein database URL information, including gene ID
annotations, chromosome coordinates, nucleotide and protein acces-
sion number annotations for human PRELI gene duplicates found in Chr
5q35.3 and Chr 6q22.32.
doi:10.1371/journal.pone.0037949.g008
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PRELI mRNA in situ hybridization was performed on normal
13.5 dpc embryo sections, covered with 4 million counts of
35S-
UTP-labeled antisense or sense complementary RNA (cRNA)
probes and hybridized overnight (ON) at 60uC. Post-hybridization
washes were processed as previously reported [51]. After ON
incubation, slides were dipped in Kodak NTB-2 emulsion and
exposed for three days. Images were acquired using an Olympus
BX60 microscope equipped with a SPOT digital camera
(Diagnostics Instruments). Also, embryo stage-specific (days post
coitum or dpc.) and multiple tissue northern (MTN) blots
(Clontech, Palo Alto CA), routinely normalized against house-
keeping transcripts, were respectively hybridized to
32P-labeled
mouse PRELI cDNA probes, as recommended by the manufac-
turer.
Confocal Fluorescence Microscopy
For sub-cellular PRELI protein localization. Control and
PRELI Blin-1 transfectants [5] were centrifuged (800 rpm) onto
slides and immediately fixed with 4% paraformaldehyde. Slides
were probed with anti-HSP60 monoclonal antibody (Stressgen
Biotechnologies, Victoria, BC, Canada) in combination with
custom-produced anti-PRELI polyclonal IgGs (Genemed Synthe-
sis, Inc., San Antonio, TX). Anti-Hsp60 and PRELI antibody
reactivities were respectively revealed by green fluorescence (Alexa
488)-conjugated anti-mouse and red fluorescence (Alexa 594)-
conjugated anti-rabbit IgGs (Molecular Probes, Eugene, OR).
For mitochondria morphology and AIF release
analyses. Control and PRELI/Blin-1 transfectants [5] were
treated with or without 1 mM STS. After an 8 hr treatment, cells
were harvested, placed onto polylysine-coated slides (CEL
Associates, Pearland, TX) and fixed with 4% paraformaldehyde.
The fixed cells were probed with polyclonal anti-AIF (Chemicon
International, Temacula, CA) IgGs. Polyclonal anti-AIF reactivity
was revealed by red fluorescence (Alexa 594)-conjugated anti-
rabbit IgGs (Molecular Probes, Eugene, OR). Images were
captured by confocal microscopy (Olympus 1X71; PMT 0-900v;
Scan speed 0.005184 sec/line). To emphasize organelle/cell
morphology and protein distribution red fluorescence, AIF images
were mounted against greyscale cell background using Adobe
Photoshop CS4 (Adobe Systems Inc. San Jose, CA) software.
Generation of CD19-Cre/Chr 13 PRELI deficient Mice
To generate conditional PRELI deficient mouse lines, the
targeting vector EASY-FLIRT was used to insert Cre recombinase
loxP recognition sequences into the Chr 13 PRELI gene locus
(Fig. 3a) in a manner so that exon II was flanked by two LoxP sites
(Floxed target). The mouse PRELI gene on chromosome 13 was
replaced by homologous recombination in 129 embryonic stem
cells. After obtaining homozygous PRELI
f/f mouse lines, animals
were extensively backcrossed into the C57BL/6 background to
produce genetically equal PRELI
f/f mouse strains. This approach
aimed to facilitate subsequent breeding schemes with most
C57BL/6-Cre mice. Wild type and heterozygous littermates were
routinely used as controls. Genotyping of the engineered mouse
lines was confirmed by PCR and Southern blot analyses. The
forward 59cttcaccctgatgctgcacgggt c39and reverse 59accgaggca-
caccccagttatct39 primer sequences that were used in the design of
PCR based experiments to assess the genotype of floxed PRELI
mouse litters are respectively located at relative PRELI genomic
positions 4298–4323 (within exon I) and 5761–5784 (intron II).
The 59 (Rab24 gene locus) and 39 (Mad3 locus) external probes, as
indicated in Figure 3a, were used in confirmatory Southern blot
analyses.
Quantitative Reverse Transcription (RT)-mediated PCR
(qRT-PCR)
Pure RNA preparations from bone marrow, peripheral blood
leukocytes (PBL) and spleen cells were obtained to quantitatively
compare PRELI mRNA expression levels between WT CD19-
Cre/Chr13 PRELI
+/+ and homozygous CD19-Cre/Chr13
PRELI
2/2 B cells using SABioscience/QIAGEN (Frederick,
MD) reagents and RT2qRT-PCR primer assay kit (Catalogue #
PPM40154). qRT-PCR reactions were carried out as reported
elsewhere [39,40,41], using SYBR Green/Rox PCR master mix
(Sabioscience, Frederick, MD, USA) in a 7500 fast real time PCR
system (Applied BioSystems, Carlsbad, CA).
PRELI transcript amplification, cloning and sequencing
Total RNA was purified from PBL of WT CD19-Cre/Chr13
PRELI
+/+, heterozygous CD19-Cre//Ch13 PRELI
+/2, and ho-
mozygous CD19-Cre/Ch13 PRELI
2/2 mouse littermates by
standard procedures. RNA was reverse-transcribed using the
Superscript II RT kit (Invitrogen, Carlsbad, CA) according to the
manufacture’s protocol. The PRELI open reading frame was
subsequently amplified by the high fidelity DNA polymerase
method (Roche, Mannheim, Germany) using forward 59aagctt-
gaattcgggacgatggtgaagtatttcct39 and reverse 59ggtaccgtcgacta-
tacgagctgccgctgctgctg39 primers that respectively included EcoR1
and Sal1 (bold font) to facilitate directional cloning. RT-PCR
products were gel-purified, cloned into the pCMV-Script vector
(Stratagene-Agilent Technologies/Genomics, Santa Clara, CA),
automatically sequenced (The University of Texas MD Anderson
Sequencing Core), and aligned for Lasergene (DNAstar, Inc.
Madison, WI) sequence analysis.
Immunoblotting
10 mg of PBL protein lysates, obtained from each WT CD19-
Cre/Chr 13 PRELI
+/+, heterozygous CD19-Cre/Chr 13 PRELI
+/
2, and homozygous CD19-Cre/Chr13 PRELI
2/2 mice were each
resolved by 12% SDS-PAGE and electro-transferred overnight
onto a nitrocellulose matrix. The blot was divided into high (above
the 35 kDa mark) and low (below the 35 kDa mark) molecular
sections and respectively reacted overnight, at 4uC, to custom-
produced polyclonal anti-MSF1-like and LEA sequence-specific
anti-PRELI IgGs (Bethyl Laboratories, Montgomery, TX). After
intense washing, reactions were revealed with HRP-conjugated
anti-rabbit IgG (Abcam) and chemilluminiscence (Pierce, Rock-
ford, IL) autoradiography, according to the manufacturer instruc-
tions.
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